Sylvan Baca: Using DNA Methylation to Uncover Drivers of Early-Onset CRC
Sylvan Baca/Kimmie Ng

Sylvan Baca: Using DNA Methylation to Uncover Drivers of Early-Onset CRC

Sylvan Baca, Assistant Professor at Harvard Medical School and the Dana-Farber Cancer Institute, shared a post on X:

“A pleasure working with David Lee and Kimmie Ng on this perspective.

Neat approach in the corresponding paper: Using DNA methylation signatures of environmental exposures to investigate what’s driving the alarming rise in early-onset colorectal cancer.”

Kimmie Ng, Director of Dana-Farber’s Young-Onset Colorectal Cancer Center, Professor at Harvard Medical School, shared Sylvan Baca’s post on X, adding:

“Excited to work on this perspective in Nature Medicine with you both! Heartened by the incredible tools we have to try to quantify exposures and better understand the etiology of young-onset CRC.”

Title: Uncovering risk factors in the exposome for early-onset colorectal cancer

Authors: David J. Lee, Sylvan Baca, Kimmie Ng

Read the article here.Sylvan Baca

Other articles featuring Sylvan Baca on OncoDaily.